Pfizer stock rockets as potential COVID-19 vaccine delivery by end of 2020

Company CEO Albert Bourla has said it is “likely” the US will get a coronavirus vaccine treatment to the public before the end of the year.

Pfizer also submitted a proposal to the FDA on Saturday that would see its late stage trial expanded, including up to 44,000 participants. This is a significant increase from its previous target of 30,000. On 8 September, nine drug companies, including Pfizer, released a joint statement to calm public fears over a vaccine being approved before being adequately tested. They pledged to prioritise safety and “uphold the integrity of the scientific process” as they each developed vaccines.

Hurry up, we need a vaccine. Charge the cost to China

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer, BioNTech propose expanding COVID-19 vaccine trial to 44,000 volunteersPfizer Inc and BioNTech SE have proposed to the U.S Food and Drug Administration (FDA) to expand the enrollment of their Phase 3 pivotal COVID-19 vaccine trial to up to about 44,000 participants, the companies said on Saturday. How much trial do you need ! COVID19 New Biotech, check this out! 44.000 volunteers, every day an idiot and rascals leave the house, when they meet, give business.
Source: Reuters - 🏆 2. / 97 Read more »